topical steroids and cyclosporin-A
PreclinicalSmall molecule
topical steroids and cyclosporin-A is one of 16 small molecule programs targeting Keratoconjunctivitis. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
15
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
28 competitors in Keratoconjunctivitis
#DrugCompanyPhaseTrials
1Neoral
NovartisApproved
Lotemax
BBausch & Lomb Incorporated
Approved
Prograf
VVeloxis Pharmaceuticals
Approved
Decadron
AAspen Global Incorporated
Approved
Cyclosporine a
NovartisApproved
FK506
AstellasPhase 3
Dupixent
AAzienda U.S.L. 1 di Massa e Carrara
Phase 2
Ciclosporin
NovartisPhase 2
Tobramycin and Dexamethasone
BBausch & Lomb Incorporated
Phase 3
NOVA22007
SSanten Inc.
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- AAmeera Gamal Abdelhameed